Levotiroxina Doc (Anhydrous Levothyroxine Sodium)

Levothyroxine is a synthetic form of T4 that, after absorption, is converted to the active T3 hormone. Both hormones bind to nuclear thyroid receptors, influencing gene expression that controls metabolism, growth, and protein synthesis, thereby correcting the deficiency seen in thyroid disorders.

The appropriate dose of Levotiroxina Doc is individualized. A prescriber determines the exact amount based on the patient’s age, weight, cardiac status, laboratory thyroid function tests, and response to therapy, and then provides specific dosing instructions.

Levothyroxine is generally considered safe in pregnancy when the lowest effective dose is used, as untreated hypothyroidism can harm both mother and fetus. Limited data exist for breastfeeding, but the drug is excreted in small amounts in milk; clinicians should monitor maternal and infant thyroid status.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levotiroxina Doc is a levothyroxine (T4) preparation, the standard of care for most thyroid‑deficient patients. Alternatives such as liothyronine (T3) provide a more rapid onset but have a shorter half‑life and may require multiple daily doses. Levothyroxine offers once‑daily dosing and stable serum levels, making it the preferred choice for most indications.

Store Levotiroxina Doc tablets at ambient temperature, preferably below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or near heat sources.

Levotiroxina Doc is taken orally, usually on an empty stomach with a full glass of water, at least 30 minutes before breakfast or other medications. Swallow the tablet whole; do not crush or chew it, as this may affect absorption.

Serious risks include cardiac arrhythmias such as atrial fibrillation, angina or myocardial infarction in patients with underlying heart disease, severe bone loss leading to osteoporosis, and hypersensitivity reactions like rash, angioedema, or anaphylaxis. Prompt medical attention is required if any of these occur.

Levotiroxina Doc should be avoided in patients with untreated adrenal insufficiency, uncorrected thyrotoxicosis, or known hypersensitivity to levothyroxine or any excipients. Caution is also advised for individuals with recent myocardial infarction or severe cardiovascular disease until stabilized.